BROOKS LABORATORIES LIMITED — M&A Activity 2026

May 14, 2026

Brooks

LABORATORIES LIMITED

Corp. Off.:- 201, "The Summit Business Bay"
Behind Guru Nanak Petrol Pump,
Off Andheri Kurla Road, Andheri (E),
Mumbai - 400 093 (India)
Ph.: +91 22 69073100

May 14, 2026

| BSE Limited
Listing Department-
Phiroze Jeejeebhoy Tower,
Dalal Street,
Mumbai – 400 001,
Scrip Code- 533543, | National Stock Exchange of India Ltd
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex,
Bandra (E)
Mumbai – 400 051,
Symbol: BROOKS |
| --- | --- |

Dear Madam/ Sir,

Sub: Update on Scheme of Arrangement involving Brooks Steriscience Limited ("BSL"), a Joint Venture / Associate of the Company.

This is further to the earlier intimation on February 6, 2026, relating to the in-principle approval received from The National Stock Exchange of India Limited and BSE Limited ("Stock Exchanges") by Onesource Specialty Pharma Limited for the proposed composite scheme of arrangement and amalgamation (merger by absorption) amongst Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited and Onesource Specialty Pharma Limited, approved by the Board of Directors of BSL ("Proposed Scheme").

In this regard, the Company has been informed by Brooks Steriscience Limited ("BSL") that at the meeting of its Board of Directors held today deliberated the proposed transaction and in the best interest of all stakeholders decided to not pursue the transaction in the current form.

You are requested to kindly take the same in record.

Thanking You.

For Brooks Laboratories Limited,

RANE
KRUTIKA
MOHAN
Digitally signed by RANE KRUTIKA
Date: 2026.05.14 18:47:12 +05'30'

Krutika Rane
Company Secretary and Compliance Office
Membership No.: 66310

Regd. Off & Works : Village Kishanpura, Baddi Nalagarh Road, Baddi (H.P.) - 174101 (India) Tele Fax : 01795 236939

(CIN NO: L24232HP2002PLC000267), E-mail : investors@brookslabs.net, Website: www.brookslabs.net